• 1
    Reale M, Patruno A, De Lutiis MA et al. Dysregulation of chemo-cytokine production in schizophrenic patients versus healthy controls. BMC Neurosci. 2011; 12: 13.
  • 2
    Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B. Meta-analysis of cytokine alterations in schizophrenia: Clinical status and antipsychotic effects. Biol. Psychiatry 2011; 70: 663671.
  • 3
    Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E. Inflammatory cytokine alterations in schizophrenia: A systematic quantitative review. Biol. Psychiatry 2008; 63: 801808.
  • 4
    Lisak RP, Nedelkoska L, Studzinski D, Bealmear B, Xu W, Benjamins JA. Cytokines regulate neuronal gene expression: Differential effects of Th1, Th2 and monocyte/macrophage cytokines. J. Neuroimmunol. 2011; 238: 1933.
  • 5
    Hegazy AN, Peine M, Helmstetter C et al. Interferons direct Th2 cell reprogramming to generate a stable GATA-3(+)T-bet(+) cell subset with combined Th2 and Th1 cell functions. Immunity 2010; 32: 116128.
  • 6
    Brown AS. Further evidence of infectious insults in the pathogenesis and pathophysiology of schizophrenia. Am J Psychiatry 2011; 168: 764766.
  • 7
    Cheng YC, Chen CC, Ho AS, Chiu NY. Prolonged psychosis associated with interferon therapy in a patient with hepatitis C: Case study and literature review. Psychosomatics 2009; 50: 538542.
  • 8
    Ariyasu T, Tanaka T, Fujioka N et al. Effects of interferon-alpha subtypes on the TH1/TH2 balance in peripheral blood mononuclear cells from patients with hepatitis virus infection-associated liver disorders. In Vitro Cell. Dev. Biol. Anim. 2005; 41: 5056.
  • 9
    Fernandez-Egea E, Garcia-Rizo C, Miller B et al. Testosterone in newly diagnosed, antipsychotic-naive men with nonaffective psychosis: A test of the accelerated aging hypothesis. Psychosom. Med. 2011; 73: 643647.
  • 10
    De Leon-Nava MA, Nava K, Soldevila G et al. Immune sexual dimorphism: Effect of gonadal steroids on the expression of cytokines, sex steroid receptors, and lymphocyte proliferation. J. Steroid Biochem. Mol. Biol. 2009; 113: 5764.
  • 11
    Sun L, Yu G, Yang S, Zhang L. Effects of hydrocortisone on the differentiation of human T helper 2 cells. Scand. J. Immunol. 2010; 73: 208214.
  • 12
    Arora S, Olszewski MA, Tsang TM, McDonald RA, Toews GB, Huffnagle GB. Effect of cytokine interplay on macrophage polarization during chronic pulmonary infection with Cryptococcus neoformans. Infect. Immun. 2011; 79: 19151926.
  • 13
    Wagner B, Burton A, Ainsworth D. Interferon-gamma, interleukin-4 and interleukin-10 production by T helper cells reveals intact Th1 and regulatory TR1 cell activation and a delay of the Th2 cell response in equine neonates and foals. Vet. Res. 2010; 41: 47.
  • 14
    Freudenreich O, Brockman MA, Henderson DC et al. Analysis of peripheral immune activation in schizophrenia using quantitative reverse-transcription polymerase chain reaction (RT-PCR). Psychiatry Res. 2010; 176: 99102.
  • 15
    O'Brien SM, Scully P, Dinan TG. Increased tumor necrosis factor-alpha concentrations with interleukin-4 concentrations in exacerbations of schizophrenia. Psychiatry Res. 2008; 160: 256262.
  • 16
    Khojasteh-Fard M, Tabrizi M, Amoli MM. Is DNA methylation responsible for immune system dysfunction in schizophrenia? Med. Hypotheses 2011; 77: 573579.
  • 17
    Barry S, Clarke G, Scully P, Dinan TG. Kynurenine pathway in psychosis: Evidence of increased tryptophan degradation. J Psychopharmacol. 2009; 23: 287294.
  • 18
    Coelho FM, Reis HJ, Nicolato R et al. Increased serum levels of inflammatory markers in chronic institutionalized patients with schizophrenia. Neuroimmunomodulation 2008; 15: 140144.
  • 19
    Avgustin B, Wraber B, Tavcar R. Increased Th1 and Th2 immune reactivity with relative Th2 dominance in patients with acute exacerbation of schizophrenia. Croat. Med. J. 2005; 46: 268274.
  • 20
    Kim YK, Myint AM, Lee BH et al. Th1, Th2 and Th3 cytokine alteration in schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2004; 28: 11291134.
  • 21
    Riedel M, Spellmann I, Schwarz MJ et al. Decreased T cellular immune response in schizophrenic patients. J. Psychiatr. Res. 2007; 41: 37.
  • 22
    Watanabe Y, Nunokawa A, Shibuya M, Kaneko N, Nawa H, Someya T. Association study of interleukin 2 (IL2) and IL4 with schizophrenia in a Japanese population. Eur. Arch. Psychiatry Clin. Neurosci. 2008; 258: 422427.
  • 23
    World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnosis Guidelines. World Health Organization, Geneva, 1994.
  • 24
    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Press, Washington, DC, 1994.
  • 25
    Schwarz MJ, Muller N, Riedel M, Ackenheil M. The Th2-hypothesis of schizophrenia: A strategy to identify a subgroup of schizophrenia caused by immune mechanisms. Med. Hypotheses 2001; 56: 483486.
  • 26
    Gabbay V, Klein RG, Alonso CM et al. Immune system dysregulation in adolescent major depressive disorder. J. Affect. Disord. 2009; 115: 177182.
  • 27
    Karanikas EP. [Psycho-immunological mechanisms in schizophrenia]. Psychiatrike 2011; 22: 4352.
  • 28
    Chen ML, Tsai TC, Lin YY et al. Antipsychotic drugs suppress the AKT/NF-kappaB pathway and regulate the differentiation of T-cell subsets. Immunol. Lett. 2011; 140: 8191.
  • 29
    Pae CU, Yoon CH, Kim TS et al. Antipsychotic treatment may alter T-helper (TH) 2 arm cytokines. Int. Immunopharmacol. 2006; 6: 666671.
  • 30
    Kim YK, Suh IB, Kim H et al. The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: Effects of psychotropic drugs. Mol. Psychiatry 2002; 7: 11071114.
  • 31
    Rothermundt M, Arolt V, Leadbeater J, Peters M, Rudolf S, Kirchner H. Cytokine production in unmedicated and treated schizophrenic patients. Neuroreport 2000; 11: 33853388.
  • 32
    Schwarz MJ, Kronig H, Riedel M et al. IL-2 and IL-4 polymorphisms as candidate genes in schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 2006; 256: 7276.
  • 33
    Paul-Samojedny M, Owczarek A, Suchanek R et al. Association study of interferon gamma (IFN-gamma) +874T/A gene polymorphism in patients with paranoid schizophrenia. J. Mol. Neurosci. 2011; 43: 309315.
  • 34
    Naz M, Riaz M, Saleem M. Potential role of Neuregulin 1 and TNF-alpha (-308) polymorphism in schizophrenia patients visiting hospitals in Lahore, Pakistan. Mol. Biol. Rep. 2010; 38: 47094714.
  • 35
    Bradford M, Law MH, Megson IL, Wei J. The functional significance of the TGM2 gene in schizophrenia: A correlation of SNPs and circulating IL-2 levels. J. Neuroimmunol. 2011; 232: 57.
  • 36
    Lung FW, Yang MC, Shu BC. The interleukin 10 promoter haplotype ACA and the long-form variant of the DRD4 uVNTR polymorphism are associated with vulnerability to schizophrenia. Psychiatry Res. 2011; 188: 294296.
  • 37
    Paul-Samojedny M, Kowalczyk M, Suchanek R et al. Functional polymorphism in the interleukin-6 and interleukin-10 genes in patients with paranoid schizophrenia: A case-control study. J. Mol. Neurosci. 2010; 42: 112119.
  • 38
    Yoshikawa T. Contribution of acquired factors to the pathogenesis of dilated cardiomyopathy – the cause of dilated cardiomyopathy: Genetic or acquired? (Acquired-Side). Circ. J. 2011; 75: 17661773; discussion 73.
  • 39
    Gogos A, Kwek P, van den Buuse M. The role of estrogen and testosterone in female rats in behavioral models of relevance to schizophrenia. Psychopharmacology (Berl) 2012; 219: 213224.
  • 40
    Soria JA, Arroyo DS, Gaviglio EA, Rodriguez-Galan MC, Wang JM, Iribarren P. Interleukin 4 induces the apoptosis of mouse microglial cells by a caspase-dependent mechanism. Neurobiol. Dis. 2011; 43: 616624.
  • 41
    Garg SK, Kipnis J, Banerjee R. IFN-gamma and IL-4 differentially shape metabolic responses and neuroprotective phenotype of astrocytes. J. Neurochem. 2009; 108: 11551166.
  • 42
    Silva SL, Vaz AR, Diogenes MJ et al. Neuritic growth impairment and cell death by unconjugated bilirubin is mediated by NO and glutamate, modulated by microglia, and prevented by glycoursodeoxycholic acid and interleukin-10. Neuropharmacology 2012; 62: 23972407.
  • 43
    Liu L, Jia F, Yuan G et al. Tyrosine hydroxylase, interleukin-1beta and tumor necrosis factor-alpha are overexpressed in peripheral blood mononuclear cells from schizophrenia patients as determined by semi-quantitative analysis. Psychiatry Res. 2010; 176: 17.
  • 44
    Belarbi K, Jopson T, Tweedie D et al. TNF-alpha protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation. J. Neuroinflammation 2012; 9: 23.
  • 45
    Azarang A, Mahmoodi M, Rajabalian S, Shekari MA, Nosratabadi J, Rezaei N. T-helper 1 and 2 serum cytokine assay in chronic opioid addicts. Eur. Cytokine Netw. 2007; 18: 210214.
  • 46
    Xu H, Zhang GX, Ciric B, Rostami A. IDO: A double-edged sword for T(H)1/T(H)2 regulation. Immunol. Lett. 2008; 121: 16.